CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Albuterol +1 moredrug
Likely dose
Albuterol 5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02802111
NCT02802111N/ACompleted
CompareCT.gov

Change in Oxygen Consumption Following Inhalation of Albuterol in Comparison With Levalbuterol in Healthy Adult Volunteers

Children's Hospital Los Angeles·interventional·Posted Jun 16, 2016·Updated Oct 28, 2020

In Brief

A clinical study evaluating Albuterol and Levalbuterol for Oxygen Consumption. Completed, enrolled 24 participants.

Detailed Summary

Albuterol is the most commonly used β agonist to treat reversible lower airway obstruction. Albuterol contains a racemic mixture of two enantiomers. Levalbuterol contains the single R form enantiomer. Levalbuterol is frequently prescribed to limit cardiovascular toxicity. The investigators sought to examine the changes in oxygen consumption (V'O2) and Heart Rate (HR) following administration of albuterol and

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOxygen Consumption
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 16, 2016
Enrollment StartJun 1, 2015
Primary CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.0 years ago

Interventions

Albuteroldrug

Patient receives albuterol 5 mg aerosolized. Oxygen consumption and vital signs are measured for 1 hour after intervention.

Levalbuteroldrug

Patient receives levalbuterol 2.5 mg aerosolized. Oxygen consumption and vital signs are measured for 1 hour after intervention